Literature DB >> 19156259

MAR elements regulate the probability of epigenetic switching between active and inactive gene expression.

José Luis Galbete1, Montserrat Buceta, Nicolas Mermod.   

Abstract

Gene expression often cycles between active and inactive states in eukaryotes, yielding variable or noisy gene expression in the short-term, while slow epigenetic changes may lead to silencing or variegated expression. Understanding how cells control these effects will be of paramount importance to construct biological systems with predictable behaviours. Here we find that a human matrix attachment region (MAR) genetic element controls the stability and heritability of gene expression in cell populations. Mathematical modeling indicated that the MAR controls the probability of long-term transitions between active and inactive expression, thus reducing silencing effects and increasing the reactivation of silent genes. Single-cell short-terms assays revealed persistent expression and reduced expression noise in MAR-driven genes, while stochastic burst of expression occurred without this genetic element. The MAR thus confers a more deterministic behavior to an otherwise stochastic process, providing a means towards more reliable expression of engineered genetic systems.

Entities:  

Mesh:

Year:  2008        PMID: 19156259     DOI: 10.1039/b813657b

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  16 in total

Review 1.  Dark matters in AMD genetics: epigenetics and stochasticity.

Authors:  Leonard M Hjelmeland
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

2.  Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver.

Authors:  Orestis Argyros; Suet Ping Wong; Constantinos Fedonidis; Oleg Tolmachov; Simon N Waddington; Steven J Howe; Marcello Niceta; Charles Coutelle; Richard P Harbottle
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

3.  Enhanced transgene expression using two β-globin MARs flanking expression cassettes in stably transfected CHO-K1 cells.

Authors:  Jihong Zhang; Junhe Zhang; Shan Cheng; Wenwen Yang; Shijiang Li
Journal:  3 Biotech       Date:  2019-11-02       Impact factor: 2.406

4.  Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells.

Authors:  Steven C L Ho; Jessna H M Yeo; Shiyi Goh Fang; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

5.  High-level transgene expression by homologous recombination-mediated gene transfer.

Authors:  Mélanie Grandjean; Pierre-Alain Girod; David Calabrese; Kaja Kostyrko; Marianne Wicht; Florence Yerly; Christian Mazza; Jacques S Beckmann; Danielle Martinet; Nicolas Mermod
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

6.  Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes.

Authors:  Stefano Majocchi; Elena Aritonovska; Nicolas Mermod
Journal:  Nucleic Acids Res       Date:  2013-09-25       Impact factor: 16.971

7.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

8.  MAR elements and transposons for improved transgene integration and expression.

Authors:  Déborah Ley; Niamh Harraghy; Valérie Le Fourn; Solenne Bire; Pierre-Alain Girod; Alexandre Regamey; Florence Rouleux-Bonnin; Yves Bigot; Nicolas Mermod
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

9.  Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors.

Authors:  Suet-Ping Wong; Richard Paul Harbottle
Journal:  Mol Ther Nucleic Acids       Date:  2013-08-13       Impact factor: 10.183

10.  Molecular characterization of a human matrix attachment region epigenetic regulator.

Authors:  Salina Arope; Niamh Harraghy; Milos Pjanic; Nicolas Mermod
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.